Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gapped down prior to trading on Wednesday . The stock had previously closed at 3.71, but opened at 3.62. Mind Medicine (MindMed) shares last traded at 3.51, with a volume of 36,662 shares.
Mind Medicine (MindMed) Company Profile (NASDAQ:MNMD)
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
See Also: Street Name
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.